Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar? von Al-Dewik, Nader I., Morsi, Hisham M., Samara, Muthanna M., Ghasoub, Rola S., Gnanam, Cinquea C., Bhaskaran, Subi K., Nashwan, Abdulqadir J., Al-Jurf, Rana M., Ismail, Mohamed A., Alsharshani, Mohammed M., Alsayab, Ali A., Ben-Omran, Tawfeg I., Khatib, Rani B., Yassin, Mohamed A.

Volltext

Is Adherence to Imatinib Mesylate Treatment among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar? von Nader I. Al-Dewik, Hisham M. Morsi, Muthanna M. Samara, Rola S. Ghasoub, Cinquea C. Gnanam, Subi K. Bhaskaran, Abdulqadir J. Nashwan, Rana M. Al-Jurf, Mohamed A. Ismail, Mohammed M. Alsharshani, Ali A. Alsayab, Tawfeg I. Ben-Omran, Rani B. Khatib, Mohamed A. Yassin

Volltext

Risk factors, diagnosis, prognosis and treatment of autism von Styles, Meghan, Alsharshani, Dalal, Samara, Muthana, Alsharshani, Mohammed, Khattab, Azhar, Qoronfleh, M Walid, Al-Dewik, Nader Izzeddin

Volltext